Clinical Trial Update: Hylenex-Assisted Resuscitation in Kenya (HARK) Trial for the Management of Dehydration [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Hylenex-assisted resuscitation for dehydration management in Kenya (HARK trial) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dehydration

Drugs mentioned

• Hylenex (hyaluronidase)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Dehydration | Phase 2 | Status: COMPLETED